Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP930732.RAbJqiyXYCtxvknePy4mldw0RQ54ftM0k47EIA8Br0Xdk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP930732.RAbJqiyXYCtxvknePy4mldw0RQ54ftM0k47EIA8Br0Xdk130_assertion type Assertion NP930732.RAbJqiyXYCtxvknePy4mldw0RQ54ftM0k47EIA8Br0Xdk130_head.
- NP930732.RAbJqiyXYCtxvknePy4mldw0RQ54ftM0k47EIA8Br0Xdk130_assertion description "[Immunostaining of ATG5 in normal prostate cells was observed in 44.9% of the cases, whereas in prostate intraepithelial neoplasm (PIN) and prostate cancer cells, ATG5 was observed in 100% and 89.7% of the cases, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930732.RAbJqiyXYCtxvknePy4mldw0RQ54ftM0k47EIA8Br0Xdk130_provenance.
- NP930732.RAbJqiyXYCtxvknePy4mldw0RQ54ftM0k47EIA8Br0Xdk130_assertion evidence source_evidence_literature NP930732.RAbJqiyXYCtxvknePy4mldw0RQ54ftM0k47EIA8Br0Xdk130_provenance.
- NP930732.RAbJqiyXYCtxvknePy4mldw0RQ54ftM0k47EIA8Br0Xdk130_assertion SIO_000772 21995634 NP930732.RAbJqiyXYCtxvknePy4mldw0RQ54ftM0k47EIA8Br0Xdk130_provenance.
- NP930732.RAbJqiyXYCtxvknePy4mldw0RQ54ftM0k47EIA8Br0Xdk130_assertion wasDerivedFrom befree-2016 NP930732.RAbJqiyXYCtxvknePy4mldw0RQ54ftM0k47EIA8Br0Xdk130_provenance.
- NP930732.RAbJqiyXYCtxvknePy4mldw0RQ54ftM0k47EIA8Br0Xdk130_assertion wasGeneratedBy ECO_0000203 NP930732.RAbJqiyXYCtxvknePy4mldw0RQ54ftM0k47EIA8Br0Xdk130_provenance.